Resource > Videos and animations >
Predicting the future: humanised drug evaluation testing using organ-on-a-chip technology
Filed under: ADME, DILI, Drug metabolism, General OOC, Immune-medicated toxicity, and Safety toxicology
CN Bio’s mission is to transform drug discovery through the development of disruptive single and multi-organ microphysiological systems (MPS) -otherwise known as organ-on-a-chip – that optimize the accuracy and efficiency of bringing new medicines to market.